Kailera Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -111,307 | -84,559 | -30,589 | -20,395 |
EBIT | -121,373 | -84,660 | -30,651 | -20,458 |
Net Income | -111,307 | -78,865 | -28,947 | -17,983 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -77,527 | -68,310 | -26,231 | -18,201 |
Cash | 130,300 | 111,826 | ||
Basic Shares | 102,226 | 117,948 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
EBITDA | -158,030 |
EBIT | -158,340 |
Net Income | -148,955 |
Net Change In Cash | 0 |
Free Cash Flow | -122,298 |
Cash | 160,267 |
Basic Shares | 117,948 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.09 |
2026-03-31 | -$3.65 |